Can a smarter blood pressure approach make stroke Clot-Busting safer?

NCT ID NCT07279259

Recruiting now Disease control Sponsor: Shanghai East Hospital Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new way to manage blood pressure in people having a stroke who receive clot-busting medication. The goal is to see if adjusting blood pressure treatment can lower the risk of bleeding in the brain. About 340 participants will be randomly assigned to either the new or standard blood pressure approach.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: adjusted blood pressure management procedure
What this could lead to: If successful, this could lead to a safer way to manage blood pressure during stroke treatment, potentially reducing the risk of brain bleeding.
What could go wrong: This is an early Phase 2 trial with only 340 participants, so results may not apply to all stroke patients. The new strategy might not lower bleeding risk and could even increase other complications.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

ischemic stroke stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE ISCHEMIC STROKE STROKE THROMBOLYSIS

Contacts and locations

Locations

Shanghai East Hospital
RECRUITING

Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.